
Tel
(853) 8822-4676
Office
N22-8014
Consultation Hours
Tue: 10:00-12:00
Thu: 15:00-17:00
Zhangfeng ZHONG 鍾章鋒
Assistant Professor
Academic Qualifications
- D.Phil. in Biomedical Sciences, University of Macau, Macao SAR, China
- M.Sc. in Chinese Medicinal Science, University of Macau, Macao SAR, China
- B.Sc. in Pharmacy, Guangdong Medical University, China
- Visiting Scholar, Northwestern University, USA
Teaching
| HSCI1006 | Organic Chemistry Laboratory | B.Sc. Course |
| HSCI3012 | Pharmaceutical Analysis | B. Sc. Course |
| CMED7017 | Across the Gap between Science and Industry | M.Sc. Course |
| CMED7006 | Introduction to Research in Medical Administration | M.Sc. Course |
| CMED7030 | Introduction to Medicinal Administration | M.Sc. Course |
Research Interests
Research Interests
- Study of Plant-derived exosome-like vesicles.
- Research and development of Chinese medicine.
- Discovery and application of natural products.
- Drug screening and lead compound analysis.
Dr. ZHONG’s group welcome MSc and PhD students, research assistants and postdocs in the field of Chinese medicine, natural products, and extracellular vesicles. Interested people could contact Dr. ZHONG at zfzhong@um.edu.mo with a complete curriculum vitae.
Representative peer-reviewed journal papers (h-index 43)
[1] Shi R, Tan W, Jin H, Chan S, Li W, Lei S, Cui G, Wang Y, Yang D, Zhong Z. MicroRNA-enriched Plant-derived Exosomes Alleviates Colitis by Modulating Systemic Immunity, Metabolic Homeostasis, and Gut Microbiota. Adv Sci. 2025, 12:e05921. [2] S Chen, C Shen, W Li, Y Fan, DH Yang, Y Wang, R Feng, G Li, Z Zhong. Recent Advances in Bioactivity-Guided Drug Screening Strategies for Pre-Clinical and Clinical Drug Discovery. Trends Analyt Chem. 2024, 181: 118042. [3] Zhu Y, Fang Y, Su L, Li X, Guo P, Duan J, Ran K, Huang N, Chen X, Chen X, Liu Y, Zhong Z*, Zhang C*, Zhang J*. Difluoroboron curcumin/glycyrrhizic acid liposome-incorporated Mg²⁺-chelated microgel for MRSA-infected wound photothermal therapy. Drug Resist Updat. 2026, 85:101347. [4] Zheng W, Chen J, Liu J, Han X, Zhang S, Yang C, Yu H, Tan W, Zhong Z. Unveiling the potential of natural TLR modulators in cancer immunotherapy. Pharmacol Res. 2025, 221:107969. [5] Yang C, Wang K, Liang Q, Tian TT, Zhong Z. Role of NSD1 as potential therapeutic target in tumor. Pharmacol Res. 2021, 173:105888. [6] Han X, Zheng W, Sun Z, Luo T, Li Z, Lai W, Jing M, Kuang M, Su H, Tan W, Zhong Z. Plant-derived exosomes: Unveiling the similarities and disparities between conventional extract and innovative form. Phytomedicine. 2025, 145:157087. [7] Shi R, Chan SI, Jin H, Li W, Zhang L, Yang J, Wang R, Zheng X, Cui G, Zhong Z. Jiegeng Gancao Decoction Ameliorates Ulcerative Colitis: An Integrative Approach Combining Network Pharmacology and Proteomics via in silico and in vivo studies. Phytomedicine. 2025, 145:156972. [8] Huang J, Shi R, Chen F, Tan HY, Zheng J, Wang N, Li R, Wang Y, Yang T, Feng Y, Zhong Z. Exploring the anti-hepatocellular carcinoma effects of Xianglian Pill: Integrating network pharmacology and RNA sequencing via in silico and in vitro studies. Phytomedicine. 2024, 133:155905. [9] Zhu Z, Cui L, Yang J, Vong CT, Hu Y, Xiao J, Chan G, He Z, Zhong Z. Anticancer effects of asiatic acid against doxorubicin-resistant breast cancer cells via an AMPK-dependent pathway in vitro. Phytomedicine. 2021, 92:153737. [10] Cui D, Qiao W, Chen W, Li P, Wang S, Wang Y, Liao F, Li F, Wang K, Wang Y, Su H, Zhong Z. Anti-tumor immunotherapy of Scutellaria baicalensis-derived vesicles on immune checkpoint modulation in colorectal cancer. Aging Dis. 2026, in press. [11] Chan KI, Zhang S, Li G, Xu Y, Cui L, Wang Y, Su H, Tan W, Zhong Z. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products. Aging Dis. 2024, 15:640. [12] Shi R#, Zhong Z#, Wang L, Mao Y, Tang Y, Wang Y, Wei J, Xie B*, Li P*. Assembly of peptide guided precise accumulation and retention of nano-herb medicine for enhanced immunotherapy of colorectal cancer. Chin Chem Let. 2025, in press. [13] Yang C, Li D, Zang S, Zhou Y, Zhang L, Zhong Z. Nanocoating of CsgA protein for enhanced cell adhesion and proliferation. Chin Chem Let. 2023, 34: 107733. [14] Chen W, Fang D, Zhang L, Kuang M, Zhang M, Shen C, Liu Y, Zhou H, Wang S, Zhao W, Wang Y, Zhong Z. Rosa Roxburghii Tratt Fruit Juice Ameliorates DSS-Induced Colitis by Repairing Intestinal Mucosal Barrier Function and Regulating Gut Microbiota in a Way Independent of Vitamin C. eFood, 2025, 6: e70084. [15] Chan S, Xiong P, Zhao M, Zhang S, Zheng R, Ye J, Chan K, Li C, Zhong Z. Anti-inflammatory effects of natural products from vitamin C-rich fruits. Food Frontiers. 2024, 5: 2383. [16] Cui D, Zhang C, Zhang L, Zheng J, Wang J, He L, Jin H, Kang Q, Zhang Y, Li N, Sun Z, Zheng W, Wei J, Zhang S, Feng Y, Tan W, Zhong Z. Natural anti-cancer products: insights from herbal medicine. Chin Med. 2025, 20:82. [17] Zhong Z, Yu H, Wang S, Wang Y, and Cui L. Anti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cells. Chin Med. 2018, 13:44. [18] Zhong Z, Vong CT, Chen F, Tan H, Zhang C, Wang N, Cui L, Wang Y, Feng Y. Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: helping to fight against cancer via multiple targets. Med Res Rev. 2022, 42:1246. [19] Zhong Z, Qiang W, Wang C, Tan W, and Wang Y. Furanodiene enhances the anti-cancer effects of doxorubicin on ERα-negative breast cancer cells in vitro. Eur J Pharmacol. 2016, 774:10. [20] Zhong Z, Tan W, Chen X, and Wang Y. Furanodiene, a natural small molecule suppressed metastatic breast cancer cell migration and invasion. Eur J Pharmacol. 2014, 737:1. [21] Zhong Z, Chen X, Tan W, Xu Z, Zhou K, Wu T, Cui L, and Wang Y. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. Eur J Pharmacol. 2011, 667:50. [22] Guan X, Zheng X, Vong C, Zhao J, Xiao J, Wang Y, Zhong Z. Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro. Eur J Pharmacol. 2020, 25:173031. [23] Li D#, Zhong Z#, Ko CN, Tian T, Yang C. From mundane to classic: Sinomenine as a multi-therapeutic agent. Br J Pharmacol. 2025, 182:2159. [24] Zhang C, Wang N, Tan HY, Guo W, Chen F, Zhong Z, Man K, Tsao SW, Lao L, Feng Y. Direct inhibition of the TLR4/MyD88 pathway by geniposide suppresses HIF-1α-independent VEGF expression and angiogenesis in hepatocellular carcinoma. Br J Pharmacol. 2020, 177:3240 [25] Huang Y, Chen C, Su M, Ye W, Wei S, Long K, Huang Y, Chen H, Zhong Z, Hou L, Zhang J, Tan W, Li F. TMEM11 promotes cisplatin resistance by inhibiting BNIP3-mediated mitophagy in bladder cancer. Cancer Lett. 2026, 641:218271. [26] Tan HY, Wang N, Chan YT, Zhang C, Guo W, Chen F, Zhong Z, Li S, Feng Y. ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis. Cancer Lett. 2020, 475:109 [27] Huang Y, Chen C, Su M, Li D, Zhang J, Long K, Nie W, Wei S, Chen W, Chen H, Zhong Z, Hou L, Tan W, Li F. MCUB Inhibits PRKN-Dependent Mitophagic Degradation of PD-L1 to Promote Immune Evasion in Bladder Cancer. Adv Sci. 2026, 13:e14764. [28] Wang K, Xie CJ, Ding Z, Shan T, Zhong Z, Yuan FL, Wu JJ, Yuan ZD, Qian C, Yu L, Liu Y, Cheng J, Zhang QL, Liu W, Zhao Y, Huang J, Zhang WZ, Yin Q, Gao BY, Hou JQ, Wang JC, Mei J, Deng C. PDE5A+ cancer-associated fibroblasts enhance immune suppression in gastric cancer. GUT, 2026, 75:486.- Zhong Z. Modern technology for monitoring cancer metastasis in Chinese medicine. In: Modern technology and progress on anti-tumor Chinese medicine. YT Wang ed., People’s Medical Publishing House, Beijing, 2012. (ISBN: 978-7-117-16227-2).
- The Science and Technology Development Fund (FDCT), Grant no: 0047/2025/ITP1, Deciphering the Molecular Code of Centella asiatica Exosomes in Intervening Inflammation-Cancer Transformation Based on the Cross-Kingdom Regulatory Network of Plant-Derived miRNAs (PI), 2025-2026
- The Science and Technology Development Fund (FDCT), Grant no: 0008/2023/RIC, The Research and Development of Chinese Medicine for Drug Registration in Macao (PI), 2024-2027
- The Science and Technology Development Fund (FDCT), Grant no: 0123/2022/A, Research and development of Chinese classical prescription Wuzhuyu Decoction (PI), 2023-2026
- The Research Fund of University of Macau, Grant no: MYRG-GRG2023-00198-ICMS, Exploring the effect of Rosa roxburghii Tratt in reshaping intestinal microenvironment and delaying inflammation-cancer transformation of colitis-associated cancer via the TLR4/MyD88 and REG3g pathways (PI), 2024-2025
- The Research Fund of University of Macau, Grant no: SRG2022-00052-ICMS, Study on the effects of EUODIAE FRUCTUS- JUJUBAE FRUCTUS drug pair in the transformation of inflammation into cancer (PI), 2022-2025
- Zhong Z, Liao F, Zhang L, et al. Preparation of exosomes derived from Schisandra chinensis and their application in liver protection. 2026, Chinese Invention Patents, 202610246530.7.
- Zhong Z, Chen S. Application of Chrysanthemum morifolium-derived exosomes. 2026, Chinese Invention Patents, 202610120083.0.
- Zhong Z, Cui D, Li P, et al. Application of Scutellaria Baicalensis-derived exosomes. 2025, Chinese Invention Patents, 202510521508.4.
- Zhong Z, Shi R, Li W, et al. Use of Centella asiatica exosomes in the preparation of drugs for the treatment of colitis. 2024, Chinese Invention Patents, 202410779535.7.
- Zhong Z, Shi R, He S, et al. A decoction device developed for Chinese classical prescriptions. 2023, Chinese Invention Patents, 202310897944.2.
- Zhong Z, Chen S, Jin H, et al. A quality testing method for Perillae fructus dispensing granules. 2024, Chinese Invention Patents, 202410570559.1.
- Wang Y, Zhong Z, Wang S, Shao S, Chen W. Application of Chinese medicine compound composition in preventing and improving Alzheimer’s disease. 2023, Chinese Invention Patents, CN 114272354 B.
- Wang Y, Chen Y, Zhong Z, Wang S, Vong C. Chinese medicine-loaded nanoparticles for the treatment of migraine and preparation method and application thereof. 2023, Chinese Invention Patents, CN 113827563 B.
- Wang Y, Chen W, Wang S, Zhong Z, Yu H. A medicinal and edible Baoyuan efferverscent tablets for enhancing immunity, and its preparation method. Chinese Invention Patents, CN114377105A. 2022
- 2023, Third Prize of 18th “Challenge Cup” National College Student Extracurricular Academic and Technological Works Competition
- 2020, First Prize of International Award for Contribution to Chinese Medicine-Achievement Award in Medical Science
- 2018, Hong Kong Scholars Award
- 2012, Macao’s Scientific and Technological R&D Award for Postgraduates
- Member, Chinese Pharmacological Society
- Council, International Society for Chinese Medicine
- Council, Word Federation of Chinese Medicine Societies
- Editor of Drug Resistance Updates (2025-)
- Guest Editor of Chinese Medicine (2023-)
- Guest Editor of Molecules (2022-)
- Guest Editor and Associate Editor of Frontiers in Immunology (2022-)
- Youth Editorial Member of Chinese Medicine (2017-)
- Review Editor of Frontiers in Pharmacology (2020-)
- Project Executive of International Society for Chinese Medicine (2018-)
- Ad-hoc reviewer of more than 10 peer-reviewed academic journals, including Molecular Cancer, Drug Resistance Updates, Advanced Science, eBioMedicine, Frontiers in Immunology, Phytomedicine, Phytotherapy Research, European Journal of Pharmacology, Journal of Ethnopharmacology, and Chinese medicine.